Biotech company to lay off 110 employees at the Ann Arbor site
ANN ARBOR, MI – An Ann Arbor biotech company announced last week that it would be laying off 110 permanent employees on Aug. 6.
Progenity, based in San Diego, announced on June 2 that it would be closing its part of the genetic testing laboratory at the Ann Arbor site for cost reasons. As a result, the laboratory will no longer offer its preparation vehicle test, the Congenital Prenatal Screen, the Riscover Hereditary Cancer Test or its Resura Prenatal Test.
The progeny are known for their genetic testing.
The layoffs are part of a wider downsizing that will result in 374 employees leaving the companies at Progenity and Avero, a subsidiary of Progenity. According to Progenity, employees make up around 56 percent of the company’s workforce.
“It’s especially hard to say goodbye to valued team members. We are grateful for their commitment and support over the past few years, ”said Harry Stylli, Chairman of the Progenity Board of Directors, in a corporate statement. “We also value the healthcare providers, patients and other interest groups who have placed their trust in us in critical life situations for more than a decade.”
Progenity reached a $ 49 million settlement with the U.S. government in July 2020 after it was accused of fraudulently billing federal health programs for prenatal testing and bribing doctors.
Progenity declined to provide additional comments.
Read more from the Ann Arbor News:
Man killed by Amtrak train near Ann Arbor Park
Kid Rock doubles its use of homophobic slander in bizarre tweets
Ann Arbor Celebrates Pride with ongoing June events; virtual event set for August